Vinbarbital
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
5-ethyl-5-[(1E)-1-methylbut-1-en-1-yl]pyrimidine-2,4,6(1H,3H,5H)-trione | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number |
2430-49-1 |
| ATC code | N05CA09 (WHO) |
| PubChem | CID 5284636 |
| ChemSpider |
4447681 |
| UNII |
7NZH2C1T6O |
| KEGG |
D07321 |
| ChEMBL |
CHEMBL503565 |
| Chemical data | |
| Formula | C11H16N2O3 |
| Molar mass | 224.256 g/mol |
| |
| |
| | |
Vinbarbital is a hypnotic drug which is a barbiturate derivative.[1] It was developed by Sharp and Dohme in 1939.[2]
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
